Cargando…

MON-037 Vitamin D Levels in Women with Polycystic Ovary Syndrome: Influence of Obesity

Introduction: Polycystic ovary syndrome (PCOS) is the most frequent cause of hyperandrogenism in women of reproductive age. Among its metabolic complications, vitamin D deficiency has been described in relation with insulin resistance’s pathophysiology and other metabolic risk factors. However, it i...

Descripción completa

Detalles Bibliográficos
Autores principales: Maidana, Patricia Nieves Amelia, Fernández, Gladys Isabel, Fritzler, Analy, Ropelato, María Gabriela, Eugenia, Lamas-Majek, Lopez, Mariana, Gonzalez, Diego, Rosales, Mónica, Leiderman, Susana Mabel, Fabre, Bibiana, Mesch, Viviana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209756/
http://dx.doi.org/10.1210/jendso/bvaa046.944
_version_ 1783531152808607744
author Maidana, Patricia Nieves Amelia
Fernández, Gladys Isabel
Fritzler, Analy
Ropelato, María Gabriela
Eugenia, Lamas-Majek
Lopez, Mariana
Gonzalez, Diego
Rosales, Mónica
Leiderman, Susana Mabel
Fabre, Bibiana
Mesch, Viviana
author_facet Maidana, Patricia Nieves Amelia
Fernández, Gladys Isabel
Fritzler, Analy
Ropelato, María Gabriela
Eugenia, Lamas-Majek
Lopez, Mariana
Gonzalez, Diego
Rosales, Mónica
Leiderman, Susana Mabel
Fabre, Bibiana
Mesch, Viviana
author_sort Maidana, Patricia Nieves Amelia
collection PubMed
description Introduction: Polycystic ovary syndrome (PCOS) is the most frequent cause of hyperandrogenism in women of reproductive age. Among its metabolic complications, vitamin D deficiency has been described in relation with insulin resistance’s pathophysiology and other metabolic risk factors. However, it is not clear if this deficiency is inherent to PCOS or it depends on adiposity degree. As well, it is also suggested that vitamin D could regulate leptin levels and high leptin levels should be associated with vitamin D defiency in obesity. Our aim was to evaluate the relationship between vitamin D, leptin and obesity degree in PCOS patients. Subjects and methods: In 84 PCOS women (19 -37 years) and 49 controls (22-45 years), 25 hidroxi-vitamin D (25 OH-D) was measured by direct chemoluminiscence. Body mass index (BMI) was calculated; 20% of PCOS women were overweight and 46% were obese. Waist circumference (WC) was measured as an indicator of abdominal obesity. The lipid accumulation product (LAP) index, a secondary marker of insulin resistance, was calculated (LAP: [waist (cm) - 58] x triglycerides (mmol/l)). In a subgroup of 26 patients, leptin levels were determined by ELISA method. Statistical analysis was performed through SPSS 22. Results: Variables are expressed as mean ± SD or median (range) according to distribution. The following parameters were higher in PCOS women than in controls, BMI: 29.3 (18.6-48.2) vs 22.4 (18.1-37.4) kg/m(2); WC 95 ± 16 vs 82 ± 11 cm and LAP: 47.9 (1.1-198.2) vs 17.5 (6.8-93.4) cm.mmol/L, p<0.0001 in all cases. 25 OH-D was lower in PCOS: 14.5 (10.0-39.0) vs 17.0 (10.0-38.8) ng/ml, p=0.024. Leptin levels in PCOS women were 10.1 ± 5.4, 26.4 ± 7.0 and 33.8 ± 16.9 ng/ml in normal weight, overweight and obese patients, respectively. After a logistic binary regression analysis, differences in 25 OH-D between groups were lost when BMI and WC were considered (p=0.556; RR=0.978; IC95% [0.909-1.063]). 25 OH-D levels were negatively associated with WC (r=-0.286, p=0.006), LAP (r=-0.333, p=0.002) and leptin (r=-0.462, p=0.017). Conclusions: although 25 OH-D levels were lower in PCOS women than in controls and negatively associated with LAP, an insulin resistant marker, the fact than differences between groups was lost after correction by BMI and WC, in addition to the correlation found between 25 OH-D and leptin levels, indicates that obesity degree and abdominal fat distribution should be responsible of decreased vitamin D levels in PCOS.
format Online
Article
Text
id pubmed-7209756
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72097562020-05-13 MON-037 Vitamin D Levels in Women with Polycystic Ovary Syndrome: Influence of Obesity Maidana, Patricia Nieves Amelia Fernández, Gladys Isabel Fritzler, Analy Ropelato, María Gabriela Eugenia, Lamas-Majek Lopez, Mariana Gonzalez, Diego Rosales, Mónica Leiderman, Susana Mabel Fabre, Bibiana Mesch, Viviana J Endocr Soc Reproductive Endocrinology Introduction: Polycystic ovary syndrome (PCOS) is the most frequent cause of hyperandrogenism in women of reproductive age. Among its metabolic complications, vitamin D deficiency has been described in relation with insulin resistance’s pathophysiology and other metabolic risk factors. However, it is not clear if this deficiency is inherent to PCOS or it depends on adiposity degree. As well, it is also suggested that vitamin D could regulate leptin levels and high leptin levels should be associated with vitamin D defiency in obesity. Our aim was to evaluate the relationship between vitamin D, leptin and obesity degree in PCOS patients. Subjects and methods: In 84 PCOS women (19 -37 years) and 49 controls (22-45 years), 25 hidroxi-vitamin D (25 OH-D) was measured by direct chemoluminiscence. Body mass index (BMI) was calculated; 20% of PCOS women were overweight and 46% were obese. Waist circumference (WC) was measured as an indicator of abdominal obesity. The lipid accumulation product (LAP) index, a secondary marker of insulin resistance, was calculated (LAP: [waist (cm) - 58] x triglycerides (mmol/l)). In a subgroup of 26 patients, leptin levels were determined by ELISA method. Statistical analysis was performed through SPSS 22. Results: Variables are expressed as mean ± SD or median (range) according to distribution. The following parameters were higher in PCOS women than in controls, BMI: 29.3 (18.6-48.2) vs 22.4 (18.1-37.4) kg/m(2); WC 95 ± 16 vs 82 ± 11 cm and LAP: 47.9 (1.1-198.2) vs 17.5 (6.8-93.4) cm.mmol/L, p<0.0001 in all cases. 25 OH-D was lower in PCOS: 14.5 (10.0-39.0) vs 17.0 (10.0-38.8) ng/ml, p=0.024. Leptin levels in PCOS women were 10.1 ± 5.4, 26.4 ± 7.0 and 33.8 ± 16.9 ng/ml in normal weight, overweight and obese patients, respectively. After a logistic binary regression analysis, differences in 25 OH-D between groups were lost when BMI and WC were considered (p=0.556; RR=0.978; IC95% [0.909-1.063]). 25 OH-D levels were negatively associated with WC (r=-0.286, p=0.006), LAP (r=-0.333, p=0.002) and leptin (r=-0.462, p=0.017). Conclusions: although 25 OH-D levels were lower in PCOS women than in controls and negatively associated with LAP, an insulin resistant marker, the fact than differences between groups was lost after correction by BMI and WC, in addition to the correlation found between 25 OH-D and leptin levels, indicates that obesity degree and abdominal fat distribution should be responsible of decreased vitamin D levels in PCOS. Oxford University Press 2020-05-08 /pmc/articles/PMC7209756/ http://dx.doi.org/10.1210/jendso/bvaa046.944 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Reproductive Endocrinology
Maidana, Patricia Nieves Amelia
Fernández, Gladys Isabel
Fritzler, Analy
Ropelato, María Gabriela
Eugenia, Lamas-Majek
Lopez, Mariana
Gonzalez, Diego
Rosales, Mónica
Leiderman, Susana Mabel
Fabre, Bibiana
Mesch, Viviana
MON-037 Vitamin D Levels in Women with Polycystic Ovary Syndrome: Influence of Obesity
title MON-037 Vitamin D Levels in Women with Polycystic Ovary Syndrome: Influence of Obesity
title_full MON-037 Vitamin D Levels in Women with Polycystic Ovary Syndrome: Influence of Obesity
title_fullStr MON-037 Vitamin D Levels in Women with Polycystic Ovary Syndrome: Influence of Obesity
title_full_unstemmed MON-037 Vitamin D Levels in Women with Polycystic Ovary Syndrome: Influence of Obesity
title_short MON-037 Vitamin D Levels in Women with Polycystic Ovary Syndrome: Influence of Obesity
title_sort mon-037 vitamin d levels in women with polycystic ovary syndrome: influence of obesity
topic Reproductive Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209756/
http://dx.doi.org/10.1210/jendso/bvaa046.944
work_keys_str_mv AT maidanapatricianievesamelia mon037vitamindlevelsinwomenwithpolycysticovarysyndromeinfluenceofobesity
AT fernandezgladysisabel mon037vitamindlevelsinwomenwithpolycysticovarysyndromeinfluenceofobesity
AT fritzleranaly mon037vitamindlevelsinwomenwithpolycysticovarysyndromeinfluenceofobesity
AT ropelatomariagabriela mon037vitamindlevelsinwomenwithpolycysticovarysyndromeinfluenceofobesity
AT eugenialamasmajek mon037vitamindlevelsinwomenwithpolycysticovarysyndromeinfluenceofobesity
AT lopezmariana mon037vitamindlevelsinwomenwithpolycysticovarysyndromeinfluenceofobesity
AT gonzalezdiego mon037vitamindlevelsinwomenwithpolycysticovarysyndromeinfluenceofobesity
AT rosalesmonica mon037vitamindlevelsinwomenwithpolycysticovarysyndromeinfluenceofobesity
AT leidermansusanamabel mon037vitamindlevelsinwomenwithpolycysticovarysyndromeinfluenceofobesity
AT fabrebibiana mon037vitamindlevelsinwomenwithpolycysticovarysyndromeinfluenceofobesity
AT meschviviana mon037vitamindlevelsinwomenwithpolycysticovarysyndromeinfluenceofobesity